Who owns SNYWhat SNY owns
What Sanofi owns
The company's own 13F portfolio · as of 2026-09-30 · long US-listed stakes only — private holdings, bonds and cash are not disclosable on a 13F
$629.9M
disclosed stock portfolio
16
positions
21.3%
in MGTX
Positions, as of 2026-09-30
ordered by filed value · % of book = share of the disclosed stock portfolio · PUT/CALL tags = options positions (share-equivalents), not shares held
| # | Issuer | Shares | Value | % of book |
|---|---|---|---|---|
| 1 | MGTXMeiraGTx Holdings plc | 12.2M | $134.2M | 21.3% |
| 2 | INBXInhibrx Biosciences, Inc. | 1.2M | $115.9M | 18.4% |
| 3 | NVAXNovavax | 6.9M | $74.4M | 11.8% |
| 4 | KRSAKorsana Biosciences | 2.0M | $63.8M | 10.1% |
| 5 | ODTXOdyssey Therapeutics Inc. | 2.0M | $44.2M | 7% |
| 6 | ANABAnaptysBio | 821,917 | $41.3M | 6.6% |
| 7 | AGMBAgomab Therapeutics NV | 2.8M | $30.9M | 4.9% |
| 8 | TRAXFirst Tracks Biotherapeutics Inc. | 821,917 | $29.1M | 4.6% |
| 9 | ETRAElectra Therapeutics Inc | 2.5M | $27.7M | 4.4% |
| 10 | ATTOAttovia Therapeutics Inc | 1.1M | $18.6M | 2.9% |
| 11 | LTGOLatigo Biotherapeutics Inc | 672,778 | $11.2M | 1.8% |
| 12 | IMRXImmuneering Corp | 2.7M | $11.1M | 1.8% |
| 13 | MPLTMapLight Therapeutics Inc. | 912,041 | $9.3M | 1.5% |
| 14 | SCTXScribe Therapeutics | 500,000 | $9.2M | 1.5% |
| 15 | SABSSAB BIOTHERAPEUTICS INC | 2.2M | $7.0M | 1.1% |
| 16 | QTTBQ32 Bio Inc. | 244,083 | $2.0M | 0.3% |
Source: SEC Form 13F-HR filed by Sanofi (CIK 1121404), reporting period 2026-09-30. Values are quarter-end filed marks. Research, not investment advice.